See feature articles below:
About Broad Street Alerts:
Big opportunities in Small Cap’s
Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!
February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%
March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.
March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.
April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.
We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.
***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
–Report on:(Nasdaq: REGN )
Currently, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been given a news sentiment score of 0. This number is provided by Beta Research using a scale from 1 to -1. A score of 1 may represent positive news sentiment, and a score of -1 may indicate the opposite. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an impact score of 0. The company’s impact score might gauge how shares could react to reported news about the company over the past day. A higher impact score may signal that the stock could see increased impact in future trading.
Zacks Research compiles analyst price targets to arrive at a short term future price projection for the stock. This one year target currently stands at $498.263. The analyst with the most conservative stance sees the stock going to $325, while the most bullish firm sees the stock reaching $668 within that same time frame.
One of the most important variables that influences share movement is future earnings projections. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will report earnings on or around 2016-05-05. Investors and analysts alike will mark their calendars to see if the company will meet or beat the consensus EPS number of $1.37 for the quarter. Last quarter the firm posted earnings of $1.46 per share, or $-1.24 away from the analyst consensus.
Source: BODY Confidential
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.
Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.